Key facts
- This page summarizes William Lis's Form 4 filing for Zai Lab Ltd (ZLAB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jul 2024, 14:04.
William Lis - 01 Jul 2024 Form 4 Insider Report for Zai Lab Ltd (ZLAB)
- Reporting relationship
- Director
- Issuer ticker
- ZLAB
- Reported as of
- 01 Jul 2024
- Net transaction value
- -$180,085
- SEC form
- 4
- Accepted by SEC
- 03 Jul 2024, 14:04:24 UTC
- Prior SEC filing
- 20 Jun 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bruce Blefeld, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William Lis filed Form 4 for Zai Lab Ltd (ZLAB) on 03 Jul 2024.
Change
- Previous filing in this sequence was filed on 20 Jun 2024.
- Current net transaction value: -$180,085.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZLAB
transaction
American Depositary Shares
Sale
- Transaction value
- $178,281
- Shares
- -10,297
- Change %
- -16%
- Price
- $17.31
- Shares after
- 53,189
- Date
- 01 Jul 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
ZLAB
transaction
American Depositary Shares
Sale
- Transaction value
- $1,804
- Shares
- -100
- Change %
- -0.19%
- Price
- $18.04
- Shares after
- 53,089
- Date
- 01 Jul 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
Footnote F2
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024.
Footnote F3
Reflects a weighted average sale price of $17.3139 per share, at prices ranging from $17.02 to $17.96 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.